Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Expo Sci Environ Epidemiol. 2014 May 7;25(3):278–285. doi: 10.1038/jes.2014.31

Table 4.

Persistent organic pollutants (POPs) and odds of fibroid diagnosis in sensitivity analysis excluding women with postoperative diagnosis of endometriosis, ENDO Study, 2005–2009 (n=283).

Fibroids only (n=63) vs. no fibroids no endo (n=220)
Omental fat
Adjusted OR (95% CI)*
Serum
Adjusted OR (95% CI)*
Analyte
HCB 0.86 (0.51, 1.44) 0.74 (0.51, 1.07)
γ-HCH 0.55 (0.27, 1.09) 0.98 (0.70, 1.38)
β-HCH 0.79 (0.51, 1.20) 1.01 (0.74, 1.39)
p,p′-DDT 1.11 (0.72, 1.71) 1.13 (0.79, 1.61)
o,p′-DDE 0.67 (0.42, 1.07) 1.01 (0.66, 1.55)
p,p′-DDE 1.19 (0.74, 1.91) 1.24 (0.87, 1.77)
CHLORDANES
 trans-chlordane 0.86 (0.52, 1.42) 0.78 (0.41, 1.47)
 cis-chlordane 1.08 (0.73, 1.60) 0.75 (0.40, 1.41)
 cis-nonachlor 0.95 (0.56, 1.61) 1.08 (0.74, 1.55)
 trans-nonachlor 1.53 (0.91, 2.58) 1.06 (0.73, 1.53)
 oxychlordane 1.61 (0.91, 2.84) 1.01 (0.59, 1.73)
PBDEs
 PBDE 47 1.08 (0.73, 1.61) 1.18 (0.82, 1.70)
 PBDE 99 1.09 (0.74, 1.60) 1.30 (0.85, 1.99)
 PBDE 100 1.07 (0.70, 1.62) 0.97 (0.64, 1.46)
 PBDE 153 1.06 (0.71, 1.58) 0.87 (0.56, 1.35)
 PBDE 154 1.11 (0.83, 1.47) 1.32 (0.88, 1.96)
 PBDE 183 0.58 (0.27, 1.23) 0.81 (0.54, 1.22)
 PBDE 209 0.93 (0.62, 1.40) 1.17 (0.84, 1.63)
PCBs
 PCB 18 1.30 (0.90, 1.88) 0.90 (0.61, 1.33)
 PCB 28 0.80 (0.45, 1.43) 1.00 (0.67, 1.51)
 PCB 44 0.93 (0.41, 2.12) 0.63 (0.35, 1.11)
 PCB 49 0.74 (0.37, 1.51) 0.67 (0.34, 1.35)
 PCB 52 0.78 (0.42, 1.45) 0.66 (0.40, 1.09)
 PCB 66 1.08 (0.82, 1.41) 0.62 (0.38, 1.01)
 PCB 74 1.33 (0.87, 2.06) 0.59 (0.33, 1.06)
 PCB 87 0.97 (0.65, 1.45) 0.73 (0.46, 1.15)
 PCB 99 1.64 (1.08, 2.49) 0.62 (0.32, 1.19)
 PCB 101 1.00 (0.56, 1.76) 0.75 (0.48, 1.17)
 PCB 118 1.27 (0.86, 1.88) 0.71 (0.39, 1.29)
 PCB 128 0.72 (0.41, 1.26) 0.84 (0.41, 1.72)
 PCB 138 1.64 (1.03, 2.59) 0.76 (0.47, 1.22)
 PCB 146 1.54 (1.01, 2.37) 0.83 (0.49, 1.41)
 PCB 149 0.89 (0.52, 1.52) 0.83 (0.53, 1.31)
 PCB 151 0.90 (0.50, 1.61) 0.84 (0.56, 1.28)
 PCB 153 1.88 (1.12, 3.13) 0.76 (0.48, 1.21)
 PCB 156 1.37 (0.96, 1.96) 0.85 (0.56, 1.28)
 PCB 157 0.80 (0.47, 1.36) 0.85 (0.56, 1.28)
 PCB 167 1.12 (0.76, 1.66) 1.05 (0.73, 1.51)
 PCB 170 1.34 (0.86, 2.11) 0.94 (0.67, 1.31)
 PCB 172 1.06 (0.72, 1.57) 1.05 (0.78, 1.40)
 PCB 177 1.32 (0.87, 1.98) 0.65 (0.41, 1.05)
 PCB 178 1.25 (0.84, 1.86) 0.89 (0.60, 1.31)
 PCB 180 1.46 (0.90, 2.39) 0.79 (0.54, 1.16)
 PCB 183 1.40 (0.91, 2.16) 0.95 (0.67, 1.35)
 PCB 187 1.31 (0.82, 2.10) 0.84 (0.58, 1.21)
 PCB 189 0.72 (0.42, 1.23) 0.94 (0.67, 1.32)
 PCB 194 1.32 (0.84, 2.09) 0.28 (0.02, 3.62)
 PCB 195 1.01 (0.66, 1.55) 1.71 (0.64, 4.54)
 PCB 196 1.60 (1.02, 2.51) 0.66 (0.27, 1.60)
 PCB 201 1.02 (0.68, 1.52) 0.61 (0.25, 1.49)
 PCB 206 1.52 (1.01, 2.29) 1.32 (0.92, 1.90)
 PCB 209 1.17 (0.75, 1.81) 0.94 (0.50, 1.77)
PFCs
 PFOS 0.88 (0.62, 1.24)
 PFOA 0.72 (0.50, 1.03)
 PFNA 0.74 (0.50, 1.08)
 PFDA 0.62 (0.39, 0.99)
 PFHxS 0.96 (0.65, 1.44)
 PFHpA 0.93 (0.64, 1.35)
 PFUNDA 1.28 (0.89, 1.84)
 PFDoDA 0.96 (0.62, 1.49)
 PFOSA 1.29 (0.90, 1.85)

All chemical concentrations were log(x+1) transformed then rescaled by the standard deviation (SD) for analysis; results are odds of a fibroids diagnosis per one SD change in POP concentration.

*

Odds ratios (OR) adjusted for age (continuous), race (black vs. others), BMI (categorical at <29.9 vs. >=30.0), smoking status (based on cotinine cutoffs of current vs. non-smoker), site, and lipid (total fat lipid or serum lipids**).

**

Serum lipid = (serum total cholesterol × 2.27) + serum triglycerides + 62.3.